To be eligible for a MammaPrint test, a breast cancer patient should fulfill the following criteria:
- Age <61 years old
- Tumor size < 5.0 cm
- Lymph node negative
- Stage 1 and Stage 2 invasive breast cancer
- ER+ or ER-
- Tamoxifen independent
MammaPrint is not be used as a stand-alone predictive test in order to determine response to chemotherapy, patient treatment or to predict the outcome of disease.

click to enlarge
|